SYTO-13, a Viability Marker as a New Tool to Monitor In Vitro Pharmacodynamic Parameters of Anti-Pneumocystis Drugs

While Pneumocystis pneumonia (PcP) still impacts the AIDS patients, it has a growing importance in immunosuppressed HIV-negative patients. To determine the anti-Pneumocystis therapeutic efficacy of new compounds, animal and in vitro models have been developed. Indeed, well-designed mouse or rat expe...

Descripción completa

Detalles Bibliográficos
Autores principales: Standaert-Vitse, Annie, Aliouat-Denis, Cécile-Marie, Martinez, Anna, Khalife, Sara, Pottier, Muriel, Gantois, Nausicaa, Dei-Cas, Eduardo, Aliouat, El Moukhtar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4477875/
https://www.ncbi.nlm.nih.gov/pubmed/26103633
http://dx.doi.org/10.1371/journal.pone.0130358

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4477875/
https://www.ncbi.nlm.nih.gov/pubmed/26103633
http://dx.doi.org/10.1371/journal.pone.0130358

Ejemplares similares